I think it's goinw to require very careful study before anyone could assume that there is such a thing as generic equivalency on a broad scale in our drug field today. There will have to be better methods of determination of equivalency than we now have,... Small Business Problems in the Drug Industry: Hearings, Ninetieth Congress ... - Page 80 by United States. Congress. House. Select Committee on Small Business. Subcommittee on Activities of Regulatory Agencies - 1967 Full view -
|